Concomitant utilization of XANAX with strong CYP3A inhibitors contains a profound impact on the clearance of alprazolam, resulting in elevated concentrations of alprazolam and elevated chance of adverse reactions [see Medical Pharmacology (twelve.three)]. Prevention or management Protracted withd